Equibles does not estimate personal net worth.
Lori Englebert has spoken on 3 earnings calls and 1 other investor event across 1 company, most recently for COMPASS Pathways plc on September 16, 2026. The companies whose calls Lori Englebert spoke on are classified in the Healthcare sector.
“Right now, there are currently 55 MDD approved products being used on an annual basis. Five of those are branded, and they're all pricing at Innovator pricing.”
“Today, there are 4 million patients with MDD who are considered treatment resistant. Spravato, the only drug indicated and used for TRD, is expected to reach $3 billion in revenue by 2027 and as of 2025 was treating less than 2% of the TRD patient population.”
“Just checking that you can hear us. yes loud and clear let me pass that to laurie hey josh this laurie thanks thanks for the question um we have not made a selection yet it's a little bit too early uh to to do that but as kabir mentioned in in the opening remarks we have you know done quite a considerable amount of…”
CMPS
Medical Care Facilities · Healthcare
